Frontlight ResearchEarly access
Sjögren's disease trials in Hungary
5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in HungaryTwo Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Where
- Budapest, Debrecen, Kaposvár, Szeged
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00 - Phase 2Not yet taking people in HungaryA Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Where
- Budapest, Budapest X, Debrecen, Kaposvár, Szeged, Zalaegerszeg
- Age
- 18 years to 100 years
- People
- 344 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00 - Phase 3Not yet taking people in HungaryPhase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Where
- Debrecen, Szeged, Székesfehérvár
- Age
- 18 years to 75 years
- People
- 250 worldwide
- Run by
- Vor Biopharma
See details and how to joinNCT07404865 · EU 2026-525556-28-00 - Phase 2Not yet taking people in HungaryA Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
- Where
- Budapest, Debrecen, Székesfehérvár
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- argenx
See details and how to joinNCT07760818 · EU 2026-526218-10-00 - Phase 3Active, not recruitingA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Where
- Budapest IX, Debrecen, Gyula, Hódmezővásárhely
- Age
- 18 years and over
- People
- 844 worldwide
- Run by
- Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00